Al the info you need on the Alzheimer's disease
 

Welcome to our Alzheimeir's Archive

 

Article #100: FDA OK's New Alzheimer's Patch

(Browse for more articles)

 
On July 9th, the Swiss Drug Maker life and remain on the planned treatment
Novartis received approval from the regiment.
American Food and Drug Administration to James Shannon, head of development at
begin selling its Exelon skin patch used Novartis said, "Innovation isn't just
to treat Alzheimer's. about developing new compounds, but also
The patch will be the first alternative about meeting therapeutic needs by taking
to the already available oral capsule for existing knowledge and applying it in new
those who suffer from the debilitating ways. Exelon Patch addresses an important
disease. medical need by delivering a proven drug
Doctor George Grossberg, MD, at St. Louis in an entirely new form that meets the
University in St. Louis, Missouri said, needs of patients and their caregivers."
"The unique delivery system helps both Alzheimer's disease is a progressive
the patient and the caregiver by degenerate disease that alters the brain
providing a much easier way to manage and causes impared thinking, memory, and
their therapy." behavior. More than 18 million people
According to initial clinical study data, worldwide suffer from the disease, 5
the patch was the preferred means of million in the US alone.
delivering medication by 70% of doctors Visit this Consumer Advocacy website for
and nurses because it was easier for the more information on ordering from an
patients to follow and use in everyday online Mexican pharmacy.






1 - A - B - C - D - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 - 11 - 12 - 13 - 14 - 15 - 16 - 17 - 18 - 19 - 20 - 21 - 22 - 23 - 24 - 25 - 26 - 27 - 28 - 29 - 30 - 31 - 32 - 33 - 34 - 35 - 36 - 37 - 38 - 39 - 40 - 41 - 42 - 43 - 44 - 45 - 46 - 47 - 48 - 49 - 50 - 51 - 52 - 53 - 54 - 55 - 56 -